Baseline prevalence and correlates of HIV and HCV infection among people who inject drugs accessing a syringe services program; Miami, FL

scientific article published on 10 June 2020

Baseline prevalence and correlates of HIV and HCV infection among people who inject drugs accessing a syringe services program; Miami, FL is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1186/S12954-020-00385-0
P932PMC publication ID7288490
P698PubMed publication ID32522201

P50authorTyler S BartholomewQ91987107
P2093author name stringDaniel J Feaster
Hardik Patel
David W Forrest
Hansel E Tookes
Jason Onugha
Carolina Scaramutti
Corinne Bullock
P2860cites workMinimising harm from hepatitis C virus needs better strategiesQ27469652
Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics supportQ29547407
Prevalence and burden of HCV co-infection in people living with HIV: a global systematic review and meta-analysisQ30251862
Survival of Hepatitis C Virus in Syringes: Implication for Transmission among Injection Drug UsersQ34101237
Estimating per-act HIV transmission risk: a systematic reviewQ34661804
Effectiveness of needle-exchange programmes for prevention of HIV infectionQ34742675
Amphetamine-type stimulants and HIV infection among men who have sex with men: implications on HIV research and prevention from a systematic review and meta-analysisQ34996496
High variability of HIV and HCV seroprevalence and risk behaviours among people who inject drugs: results from a cross-sectional study using respondent-driven sampling in eight German cities (2011-14).Q36123087
Facilitating entry into drug treatment among injection drug users referred from a needle exchange program: Results from a community-based behavioral intervention trialQ36376967
Clear Links Between Starting Methamphetamine and Increasing Sexual Risk Behavior: A Cohort Study Among Men Who Have Sex With Men.Q36678117
Transmission of hepatitis C virus among people who inject drugs: viral stability and association with drug preparation equipmentQ36727287
Higher syringe coverage is associated with lower odds of HIV risk and does not increase unsafe syringe disposal among syringe exchange program clients.Q36926250
Consequences of a restrictive syringe exchange policy on utilisation patterns of a syringe exchange program in Baltimore, Maryland: Implications for HIV riskQ36939938
Lifetime risk of a diagnosis of HIV infection in the United StatesQ38888885
State of HIV in the US Deep SouthQ38936501
Intersecting epidemics--crack cocaine use and HIV infection among inner-city young adults. Multicenter Crack Cocaine and HIV Infection Study TeamQ39391339
Increases in hepatitis C virus infection related to injection drug use among persons aged ≤30 years - Kentucky, Tennessee, Virginia, and West Virginia, 2006-2012.Q40278327
Correlates of hepatitis C virus infections among injection drug users.Q40453200
Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic reviewQ42699381
Prevalence of hepatitis C virus infection among injection drug users in the United States, 1994-2004.Q42978282
Comparison of hepatitis B virus and hepatitis C virus prevalence and risk factors in a community-based study.Q43039376
Viral hepatitis and other infectious diseases in a homeless populationQ43926303
Crack cocaine use and adherence to antiretroviral treatment among HIV-infected black womenQ44831221
Hepatitis C virus (HCV) prevalence, and injecting risk behaviour in multiple sites in England in 2004.Q45401216
Risk of hepatitis C virus infection among young adult injection drug users who share injection equipmentQ45733180
Predicting HIV transmission risk among HIV-infected men who have sex with men: findings from the healthy living projectQ46714910
Syringe sharing and HIV incidence among injection drug users and increased access to sterile syringes.Q51688513
Sharing of drug preparation equipment as a risk factor for hepatitis CQ73466639
The force of numbers: why hepatitis C is spreading among Australian injecting drug users while HIV is notQ74638799
Hospitalized HIV-infected patients in the era of highly active antiretroviral therapyQ83668498
Temporal relations between methamphetamine use and HIV seroconversion in gay, bisexual, and other men who have sex with menQ87375749
Resurgent Methamphetamine Use at Treatment Admission in the United States, 2008-2017Q89801260
Examining risk behavior and syringe coverage among people who inject drugs accessing a syringe services program: A latent class analysisQ90133106
The Opioid Crisis in Black CommunitiesQ91149199
Sharing of Injection Drug Preparation Equipment Is Associated With HIV Infection: A Cross-sectional StudyQ91508368
Impacts of mandated data collection on syringe distribution programs in the United StatesQ91664217
P433issue1
P304page(s)40
P577publication date2020-06-10
P1433published inHarm Reduction JournalQ15746441
P1476titleBaseline prevalence and correlates of HIV and HCV infection among people who inject drugs accessing a syringe services program; Miami, FL
P478volume17